Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FBNXY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,620
Award facts
- Contract value 100% obligated
- $21,620.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on October 20, 2025. This competitively awarded, firm fixed-price delivery order has a ceiling value of $21,620.23 and is scheduled for completion by October 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract carries no set-aside designation, reflecting the competitive procurement process.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Zepbound, a weight management medication, represents one of the specialized pharmaceutical products available under this framework contract, which serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen Drug Corp maintains a significant position as a critical pharmaceutical vendor for federal medical procurement, leveraging its extensive capabilities to fulfill diverse medical supply needs through both small-value and substantial orders across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FBNXY?
SPE2DB26FBNXY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DB26FBNXY worth?
The government has obligated $21,620 on SPE2DB26FBNXY.
Is contract SPE2DB26FBNXY an order under another contract?
Yes. SPE2DB26FBNXY is a delivery order under SPE2DB24D2011, an indefinite delivery contract.
Was contract SPE2DB26FBNXY competed?
The extent of competition for SPE2DB26FBNXY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award